Downloads: 1
| # | consensuscluster | class | Timepoint_coded | Treatment | pam50 | Mammaprint_risk | rorS_risk | scmod1 | IC10 |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | Non_responder | T1 | Endocrine_treatment | Her2 | 1 | High | HER2+ | iC1 |
| 2 | 1 | Responder | T1 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- High Prolif | iC1 |
| 3 | 1 | Responder | T1 | Endocrine_treatment | LumA | 1 | Intermediate | ER+/HER2- High Prolif | iC9 |
| 4 | 1 | Non_responder | T1 | Chemotherapy | LumB | 1 | High | ER+/HER2- High Prolif | iC6 |
| 5 | 1 | Non_responder | T1 | Chemotherapy | LumA | 1 | Intermediate | ER+/HER2- High Prolif | iC8 |
| 6 | 1 | Non_responder | T1 | Chemotherapy | LumA | 1 | Intermediate | ER+/HER2- High Prolif | iC2 |
| 7 | 1 | Responder | T2 | Chemotherapy | Her2 | 1 | High | HER2+ | iC4 |
| 8 | 1 | Responder | T1 | Chemotherapy | Her2 | 1 | High | HER2+ | iC2 |
| 9 | 1 | Responder | T1 | Endocrine_treatment | LumA | 1 | Intermediate | ER+/HER2- High Prolif | iC8 |
| 10 | 1 | Non_responder | T1 | Chemotherapy | LumB | 1 | Intermediate | ER+/HER2- High Prolif | iC3 |
| 11 | 1 | Responder | T1 | Endocrine_treatment | Her2 | 1 | High | HER2+ | iC4 |
| 12 | 1 | Non_responder | T1 | Chemotherapy | Her2 | 1 | High | ER-/HER2- | iC4 |
| 13 | 1 | Responder | T2 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- High Prolif | iC2 |
| 14 | 1 | Responder | T2 | Endocrine_treatment | LumB | 1 | Intermediate | ER+/HER2- High Prolif | iC2 |
| 15 | 1 | Non_responder | T2 | Chemotherapy | Basal | 1 | High | ER-/HER2- | iC4 |
| 16 | 1 | Responder | T2 | Endocrine_treatment | LumA | 0 | Low | ER+/HER2- Low Prolif | iC3 |
| 17 | 1 | Responder | T2 | Endocrine_treatment | LumB | 1 | Intermediate | ER-/HER2- | iC4 |
| 18 | 1 | Responder | T2 | Chemotherapy | Basal | 1 | High | HER2+ | iC4 |
| 19 | 1 | Responder | T2 | Endocrine_treatment | LumA | 0 | Intermediate | ER+/HER2- Low Prolif | iC7 |
| 20 | 1 | Responder | T2 | Endocrine_treatment | Her2 | 1 | Intermediate | ER+/HER2- Low Prolif | iC7 |
| 21 | 1 | Responder | T2 | Endocrine_treatment | Basal | 1 | Intermediate | ER-/HER2- | iC4 |
| 22 | 1 | Responder | T2 | Endocrine_treatment | LumB | 1 | High | ER-/HER2- | iC3 |
| 23 | 1 | Responder | T2 | Endocrine_treatment | LumB | 1 | Intermediate | ER+/HER2- High Prolif | iC9 |
| 24 | 1 | Responder | T2 | Chemotherapy | Basal | 1 | High | ER-/HER2- | iC4 |
| 25 | 1 | Responder | T1 | Chemotherapy | Basal | 1 | High | ER-/HER2- | iC3 |
| 26 | 1 | Responder | T1 | Chemotherapy | Her2 | 1 | High | ER-/HER2- | iC4 |
| 27 | 1 | Non_responder | T1 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- High Prolif | iC4 |
| 28 | 1 | Responder | T2 | Endocrine_treatment | LumA | 1 | Intermediate | ER-/HER2- | iC4 |
| 29 | 1 | Responder | T2 | Endocrine_treatment | Normal | 1 | Intermediate | ER-/HER2- | iC4 |
| 30 | 1 | Responder | T2 | Chemotherapy | Her2 | 1 | High | ER-/HER2- | iC4 |
| 31 | 1 | Responder | T1 | Endocrine_treatment | LumA | 1 | Low | ER+/HER2- Low Prolif | iC4 |
| 32 | 1 | Responder | T1 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- Low Prolif | iC7 |
| 33 | 1 | Responder | T1 | Endocrine_treatment | LumB | 1 | High | ER-/HER2- | iC3 |
| 34 | 1 | Non_responder | T2 | Chemotherapy | Basal | 1 | High | ER-/HER2- | iC4 |
| 35 | 1 | Responder | T1 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- High Prolif | iC7 |
| 36 | 1 | Non_responder | T2 | Endocrine_treatment | Basal | 1 | High | HER2+ | iC4 |
| 37 | 1 | Responder | T1 | Endocrine_treatment | Basal | 1 | High | ER+/HER2- High Prolif | iC7 |
| 38 | 1 | Responder | T2 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- High Prolif | iC7 |
| 39 | 1 | Responder | T2 | Endocrine_treatment | LumA | 1 | Intermediate | ER+/HER2- High Prolif | iC1 |
| 40 | 1 | Non_responder | T1 | Chemotherapy | LumA | 1 | Intermediate | ER+/HER2- High Prolif | iC7 |
| 41 | 1 | Non_responder | T1 | Chemotherapy | LumA | 1 | Low | ER+/HER2- High Prolif | iC8 |
| 42 | 1 | Non_responder | T2 | Endocrine_treatment | LumA | 1 | Low | ER+/HER2- High Prolif | iC7 |
| 43 | 1 | Non_responder | T1 | Chemotherapy | LumB | 1 | High | ER+/HER2- Low Prolif | iC3 |
| 44 | 1 | Responder | T1 | Endocrine_treatment | LumB | 1 | Intermediate | ER+/HER2- Low Prolif | iC8 |
| 45 | 1 | Non_responder | T1 | Endocrine_treatment | Basal | 1 | Intermediate | ER+/HER2- High Prolif | iC8 |
| 46 | 1 | Non_responder | T1 | Chemotherapy | LumA | 1 | Intermediate | ER+/HER2- High Prolif | iC8 |
| 47 | 1 | Non_responder | T2 | Chemotherapy | Her2 | 1 | High | ER+/HER2- High Prolif | iC4 |
| 48 | 1 | Non_responder | T2 | Endocrine_treatment | LumB | 1 | High | HER2+ | iC1 |
| 49 | 1 | Non_responder | T2 | Endocrine_treatment | Normal | 1 | Low | HER2+ | iC4 |
| 50 | 1 | Non_responder | T2 | Chemotherapy | LumA | 1 | Low | ER+/HER2- High Prolif | iC6 |
| 51 | 1 | Non_responder | T1 | Chemotherapy | LumB | 0 | Low | ER+/HER2- Low Prolif | iC7 |
| 52 | 1 | Non_responder | T1 | Chemotherapy | Her2 | 1 | High | ER-/HER2- | iC3 |
| 53 | 1 | Responder | T2 | Chemotherapy | Normal | 1 | Intermediate | ER+/HER2- High Prolif | iC3 |
| 54 | 1 | Responder | T1 | Chemotherapy | LumA | 1 | Low | ER+/HER2- High Prolif | iC3 |
| 55 | 1 | Responder | T1 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- High Prolif | iC3 |
| 56 | 1 | Responder | T2 | Endocrine_treatment | LumA | 1 | Intermediate | ER+/HER2- High Prolif | iC8 |
| 57 | 1 | Responder | T2 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- High Prolif | iC8 |
| 58 | 1 | Responder | T1 | Endocrine_treatment | Normal | 1 | Low | ER+/HER2- High Prolif | iC4 |
| 59 | 1 | Non_responder | T2 | Chemotherapy | LumB | 1 | Intermediate | ER+/HER2- High Prolif | iC3 |
| 60 | 1 | Responder | T1 | Endocrine_treatment | LumB | 1 | Intermediate | ER+/HER2- High Prolif | iC9 |
| 61 | 1 | Responder | T1 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- High Prolif | iC8 |
| 62 | 1 | Non_responder | T2 | Endocrine_treatment | LumA | 1 | Intermediate | ER+/HER2- High Prolif | iC7 |
| 63 | 1 | Responder | T2 | Endocrine_treatment | LumA | 0 | Low | ER+/HER2- Low Prolif | iC1 |
| 64 | 1 | Responder | T1 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- High Prolif | iC7 |
| 65 | 1 | Non_responder | T1 | Chemotherapy | LumA | 1 | Low | ER+/HER2- High Prolif | iC3 |
| 66 | 1 | Non_responder | T1 | Chemotherapy | LumA | 1 | Intermediate | ER+/HER2- High Prolif | iC5 |
| 67 | 1 | Responder | T1 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- High Prolif | iC3 |
| 68 | 1 | Non_responder | T1 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- Low Prolif | iC4 |
| 69 | 1 | Non_responder | T1 | Endocrine_treatment | Her2 | 1 | High | HER2+ | iC7 |
| 70 | 1 | Non_responder | T1 | Chemotherapy | Her2 | 1 | High | ER+/HER2- Low Prolif | iC4 |
| 71 | 1 | Responder | T1 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- High Prolif | iC4 |
| 72 | 1 | Responder | T2 | Endocrine_treatment | Normal | 1 | Low | ER+/HER2- Low Prolif | iC3 |
| 73 | 1 | Responder | T1 | Endocrine_treatment | LumB | 1 | Intermediate | ER+/HER2- Low Prolif | iC3 |
| 74 | 1 | Responder | T1 | Chemotherapy | Her2 | 1 | Intermediate | HER2+ | iC5 |
| 75 | 1 | Responder | T1 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- High Prolif | iC3 |
| 76 | 1 | Non_responder | T2 | Endocrine_treatment | LumA | 1 | Low | ER+/HER2- Low Prolif | iC4 |
| 77 | 1 | Non_responder | T2 | Endocrine_treatment | LumA | 0 | Low | HER2+ | iC3 |
| 78 | 1 | Non_responder | T2 | Endocrine_treatment | Normal | 1 | Low | ER-/HER2- | iC6 |
| 79 | 1 | Non_responder | T2 | Endocrine_treatment | LumB | 1 | Intermediate | ER-/HER2- | iC3 |
| 80 | 1 | Non_responder | T2 | Endocrine_treatment | Normal | 1 | Low | ER-/HER2- | iC4 |
| 81 | 1 | Non_responder | T2 | Chemotherapy | Basal | 1 | High | ER-/HER2- | iC4 |
| 82 | 1 | Non_responder | T2 | Chemotherapy | Basal | 1 | Intermediate | ER-/HER2- | iC4 |
| 83 | 1 | Non_responder | T2 | Chemotherapy | Her2 | 1 | Intermediate | HER2+ | iC3 |
| 84 | 1 | Non_responder | T2 | Chemotherapy | LumA | 0 | Low | ER+/HER2- Low Prolif | iC7 |
| 85 | 1 | Non_responder | T2 | Chemotherapy | Her2 | 0 | Low | ER-/HER2- | iC4 |
| 86 | 1 | Non_responder | T2 | Chemotherapy | LumA | 0 | Low | ER+/HER2- Low Prolif | iC7 |
| 87 | 1 | Non_responder | T2 | Chemotherapy | LumA | 1 | Low | ER+/HER2- Low Prolif | iC8 |
| 88 | 1 | Non_responder | T2 | Chemotherapy | LumA | 1 | Intermediate | ER+/HER2- Low Prolif | iC3 |
| 89 | 1 | Non_responder | T2 | Chemotherapy | Normal | 1 | Low | ER-/HER2- | iC4 |
| 90 | 1 | Non_responder | T1 | Endocrine_treatment | LumA | 1 | Low | ER+/HER2- Low Prolif | iC3 |
| 91 | 1 | Non_responder | T1 | Endocrine_treatment | LumA | 0 | Low | ER+/HER2- Low Prolif | iC4 |
| 92 | 1 | Non_responder | T1 | Endocrine_treatment | Normal | 1 | Low | ER-/HER2- | iC3 |
| 93 | 1 | Non_responder | T1 | Endocrine_treatment | LumA | 1 | High | ER+/HER2- Low Prolif | iC8 |
| 94 | 1 | Non_responder | T1 | Endocrine_treatment | LumB | 1 | High | ER+/HER2- High Prolif | iC3 |
| 95 | 1 | Non_responder | T1 | Chemotherapy | Basal | 1 | Intermediate | ER-/HER2- | iC4 |
| 96 | 1 | Non_responder | T1 | Chemotherapy | LumA | 0 | Low | ER+/HER2- Low Prolif | iC3 |
| 97 | 1 | Non_responder | T1 | Chemotherapy | LumB | 1 | Intermediate | ER+/HER2- High Prolif | iC1 |
| 98 | 1 | Non_responder | T1 | Chemotherapy | LumA | 0 | Low | ER+/HER2- Low Prolif | iC5 |
| 99 | 1 | Non_responder | T1 | Chemotherapy | LumA | 0 | Low | ER-/HER2- | iC4 |
| 100 | 1 | Non_responder | T1 | Chemotherapy | Her2 | 1 | Intermediate | HER2+ | iC7 |